You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Solid Tumor types likely to exhibit elevated levels of Epidermal Growth Factor Receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer Trial in Durham (pING-hHER3FL)

Recruiting
  • Advanced Cancer
  • pING-hHER3FL
  • Durham, North Carolina
    Duke University Medical Center
Nov 4, 2022

Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor Trial (INX-315)

Not yet recruiting
  • Breast Cancer
  • +8 more
  • (no location specified)
Feb 9, 2023

NSCLC Trial in Canada (Osimertinib First-Line, Platinum + Pemetrexed Chemotherapy Second-Line, Osimertinib Third-Line)

Recruiting
  • Non-Small Cell Lung Cancer
  • Osimertinib First-Line
  • +2 more
  • Vancouver, British Columbia, Canada
  • +9 more
Jun 21, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 2, 2023

Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T

Not yet recruiting
  • Recurrent Glioblastoma
  • Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
  • (no location specified)
Apr 4, 2023

Solid Tumor Trial in Seoul (Gefitinib)

Completed
  • Solid Tumor
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

Recruiting
  • Non-small Cell Lung Cancer
  • SH-1028 tablets
  • Placebo SH-1028 tablets
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Oct 6, 2023

Advanced Solid Tumors Cancer Trial in Australia, Israel, United States (ABBV-321)

Completed
  • Advanced Solid Tumors Cancer
  • Springdale, Arkansas
  • +17 more
May 5, 2021

Head and Neck Squamous Cell Carcinoma, NSCLC, Triple Negative Breast Cancer Trial in Boston, San Antonio, Madrid (ABBV-221)

Terminated
  • Head and Neck Squamous Cell Carcinoma
  • +4 more
  • Boston, Massachusetts
  • +4 more
Mar 28, 2018

Squamous-cell NSCLC Trial in Switzerland (Rogaratinib)

Active, not recruiting
  • Squamous-cell Non-small Cell Lung Cancer
  • Baden, Switzerland
  • +10 more
Jan 20, 2022

Breast Tumors Trial in Beijing, Nanjing, Changsha (Disitamab Vedotin, Toripalimab)

Not yet recruiting
  • Breast Neoplasms
  • Beijing, Cancer Hospital Chinese Academy Of Medical Sciences, China
  • +2 more
Oct 23, 2023

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

Metastatic Sporadic Medullary Thyroid Cancer Patients and

Completed
  • Metastatic Sporadic Medullary Thyroid Cancer
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
    Sep 29, 2021

    Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))

    Not yet recruiting
    • Breast Cancer
    • Metastatic Breast Cancer
    • Trastuzumab-Deruxtecan (T-DXd)
    • (no location specified)
    Sep 20, 2023

    Solid Tumor Trial in Worldwide (BDTX-189)

    Terminated
    • Solid Tumor
    • Scottsdale, Arizona
    • +37 more
    Oct 13, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)

    Active, not recruiting
    Has Results
    • Non Small Cell Lung Cancer
    • La Jolla, California
    • +43 more
    Nov 25, 2022

    Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Jul 12, 2023

    Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in United States (drug, other, biological)

    Suspended
    • Metastatic Breast Carcinoma
    • Stage IV Breast Cancer AJCC v6 and v7
    • Corona, California
    • +6 more
    Sep 28, 2022

    Gastric Cancer Trial in Goyang (CKD-702 in combination with irinotecan)

    Recruiting
    • Gastric Cancer
    • CKD-702 in combination with irinotecan
    • Goyang, Gyeonggi, Korea, Republic of
      National Cancer Center
    Feb 20, 2023

    Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

    Active, not recruiting
    • Breast Cancer
    • Aurora, Colorado
    • +23 more
    Jan 30, 2023

    Solid Tumor, Adult Trial in Kansas City, Providence (DF9001, Nivolumab)

    Not yet recruiting
    • Solid Tumor, Adult
    • Kansas City, Missouri
    • +1 more
    Oct 24, 2022

    Cervical Cancer Trial (Nimotuzumab?Tislelizumab)

    Not yet recruiting
    • Cervical Cancer
    • (no location specified)
    Sep 9, 2023

    Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

    Not yet recruiting
    • Breast Cancer
    • Beijing, Benjing, China
    • +2 more
    Dec 30, 2022

    Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

    Recruiting
    • Breast Cancer
    • ARV-471 (PF-07850327)
    • +2 more
    • Orange City, Florida
      Mid Florida Hematology and Oncology Center
    Jun 8, 2023

    NSCLC Trial in Australia, China, Korea, Republic of (AZD9291)

    Active, not recruiting
    Has Results
    • Non-Small Cell Lung Cancer
    • Kogarah, Australia
    • +29 more
    Oct 20, 2022